Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio for February 2026

Extreme outlier transactions (>3ฯƒ) are excluded.Show All Data
Ratio0.2:1
Daily Buy & Sell Volume

By Sector

By Industry

DoorDash, Inc. (DASH)

Tang Stanley โ€” Director
Feb 2, 2026
Sale
Shares
11,800
Price
$208.89
Total Value
$2.46M
Shares Held After
15,284
% of Holdings
43.6%

DoorDash, Inc. (DASH)

Tang Stanley โ€” Director
Feb 2, 2026
Sale
Shares
16,766
Price
$207.97
Total Value
$3.49M
Shares Held After
27,084
% of Holdings
38.2%

DoorDash, Inc. (DASH)

Tang Stanley โ€” Director
Feb 2, 2026
Sale
Shares
1,000
Price
$207.17
Total Value
$207.17K
Shares Held After
43,850
% of Holdings
2.2%

DoorDash, Inc. (DASH)

Tang Stanley โ€” Director
Feb 2, 2026
Sale
Shares
560
Price
$204.05
Total Value
$114.27K
Shares Held After
44,850
% of Holdings
1.2%

Amylyx Pharmaceuticals, Inc. (AMLX)

FRATES JAMES M โ€” Chief Financial Officer
Feb 2, 2026
Sale
Shares
3,557
Price
$14.65
Total Value
$52.10K
Shares Held After
173,547
% of Holdings
2.0%

REVVITY, INC. (RVTY)

Vohra Tajinder S โ€” Senior Vice President, Global Operations
Feb 2, 2026
Sale
Shares
5,756
Price
$104.50
Total Value
$601.50K
Shares Held After
10,442
% of Holdings
35.5%

IONIS PHARMACEUTICALS INC (IONS)

BENNETT C FRANK โ€” EVP, Chief Scientific Officer
Feb 2, 2026
Sale
Shares
16,463
Price
$83.03
Total Value
$1.37M
Shares Held After
80,293
% of Holdings
17.0%

IONIS PHARMACEUTICALS INC (IONS)

BENNETT C FRANK โ€” EVP, Chief Scientific Officer
Feb 2, 2026
Sale
Shares
48,626
Price
$83.03
Total Value
$4.04M
Shares Held After
80,293
% of Holdings
37.7%

IONIS PHARMACEUTICALS INC (IONS)

BENNETT C FRANK โ€” EVP, Chief Scientific Officer
Feb 2, 2026
Sale
Shares
20,000
Price
$82.60
Total Value
$1.65M
Shares Held After
80,293
% of Holdings
19.9%

Morningstar, Inc. (MORN)

Mansueto Joseph D โ€” Director
Feb 2, 2026
Sale
Shares
418
Price
$203.34
Total Value
$85.00K
Shares Held After
8,237,375
% of Holdings
0.0%

Morningstar, Inc. (MORN)

Mansueto Joseph D โ€” Director
Feb 2, 2026
Sale
Shares
439
Price
$201.47
Total Value
$88.45K
Shares Held After
8,237,793
% of Holdings
0.0%
Feb 2, 2026
Sale
Shares
73,537
Price
$136.58
Total Value
$10.04M
Shares Held After
194,817
% of Holdings
27.4%
Feb 2, 2026
Sale
Shares
73,390
Price
$136.57
Total Value
$10.02M
Shares Held After
268,354
% of Holdings
21.5%
Feb 2, 2026
Sale
Shares
19,834
Price
$135.56
Total Value
$2.69M
Shares Held After
341,744
% of Holdings
5.5%
Feb 2, 2026
Sale
Shares
19,734
Price
$135.54
Total Value
$2.67M
Shares Held After
361,578
% of Holdings
5.2%
Feb 2, 2026
Sale
Shares
7,845
Price
$137.09
Total Value
$1.08M
Shares Held After
381,312
% of Holdings
2.0%
Feb 2, 2026
Sale
Shares
7,598
Price
$137.08
Total Value
$1.04M
Shares Held After
389,157
% of Holdings
1.9%
Feb 2, 2026
Sale
Shares
15,000
Price
$10.72
Total Value
$160.86K
Shares Held After
454,864
% of Holdings
3.2%

Dolby Laboratories, Inc. (DLB)

Couling John D โ€” SVP, Entertainment
Feb 2, 2026
Sale
Shares
6,667
Price
$64.89
Total Value
$432.59K
Shares Held After
123,041
% of Holdings
5.1%
Feb 2, 2026
Sale
Shares
83,689
Price
$1.39
Total Value
$116.33K
Shares Held After
3,297,794
% of Holdings
2.5%
Feb 2, 2026
Sale
Shares
114,891
Price
$1.39
Total Value
$159.70K
Shares Held After
3,206,233
% of Holdings
3.5%
Feb 2, 2026
Sale
Shares
96,065
Price
$1.39
Total Value
$133.53K
Shares Held After
3,321,124
% of Holdings
2.8%
Feb 2, 2026
Sale
Shares
46,660
Price
$1.39
Total Value
$64.86K
Shares Held After
3,417,189
% of Holdings
1.3%

Doximity, Inc. (DOCS)

Wampler Kira Scherer โ€” Director
Feb 2, 2026
Sale
Shares
2,000
Price
$37.33
Total Value
$74.66K
Shares Held After
19,839
% of Holdings
9.2%

Akebia Therapeutics, Inc. (AKBA)

Ostrowski Erik โ€” SVP, CFO, CBO & Treasurer
Feb 2, 2026
Sale
Shares
34,951
Price
$1.39
Total Value
$48.58K
Shares Held After
672,635
% of Holdings
4.9%

Akebia Therapeutics, Inc. (AKBA)

Rucci Carolyn M. โ€” SVP, Chief Legal Officer
Feb 2, 2026
Sale
Shares
27,544
Price
$1.39
Total Value
$38.29K
Shares Held After
588,378
% of Holdings
4.5%

Akebia Therapeutics, Inc. (AKBA)

Rucci Carolyn M. โ€” SVP, Chief Legal Officer
Feb 2, 2026
Sale
Shares
25,382
Price
$1.39
Total Value
$35.28K
Shares Held After
615,922
% of Holdings
4.0%

Akebia Therapeutics, Inc. (AKBA)

Rucci Carolyn M. โ€” SVP, Chief Legal Officer
Feb 2, 2026
Sale
Shares
16,846
Price
$1.39
Total Value
$23.42K
Shares Held After
641,304
% of Holdings
2.6%

Akebia Therapeutics, Inc. (AKBA)

Burke Steven Keith โ€” SVP, Chief Medical Officer
Feb 2, 2026
Sale
Shares
20,701
Price
$1.39
Total Value
$28.77K
Shares Held After
948,432
% of Holdings
2.1%

Akebia Therapeutics, Inc. (AKBA)

Burke Steven Keith โ€” SVP, Chief Medical Officer
Feb 2, 2026
Sale
Shares
25,375
Price
$1.39
Total Value
$35.27K
Shares Held After
969,133
% of Holdings
2.6%

Akebia Therapeutics, Inc. (AKBA)

Burke Steven Keith โ€” SVP, Chief Medical Officer
Feb 2, 2026
Sale
Shares
21,582
Price
$1.39
Total Value
$30.00K
Shares Held After
994,508
% of Holdings
2.1%

Akebia Therapeutics, Inc. (AKBA)

Grund Nicholas โ€” Chief Commercial Officer
Feb 2, 2026
Sale
Shares
31,244
Price
$1.39
Total Value
$43.43K
Shares Held After
561,750
% of Holdings
5.3%

Akebia Therapeutics, Inc. (AKBA)

Grund Nicholas โ€” Chief Commercial Officer
Feb 2, 2026
Sale
Shares
53,585
Price
$1.39
Total Value
$74.48K
Shares Held After
592,994
% of Holdings
8.3%

NOVANTA INC (NOVT)

Glastra Matthijs โ€” Director
Feb 2, 2026
Sale
Shares
48
Price
$137.38
Total Value
$6.59K
Shares Held After
64,867
% of Holdings
0.1%

NOVANTA INC (NOVT)

Glastra Matthijs โ€” Director
Feb 2, 2026
Sale
Shares
1,108
Price
$136.54
Total Value
$151.29K
Shares Held After
64,915
% of Holdings
1.7%

NOVANTA INC (NOVT)

Glastra Matthijs โ€” Director
Feb 2, 2026
Sale
Shares
1,738
Price
$135.50
Total Value
$235.50K
Shares Held After
66,023
% of Holdings
2.6%

NOVANTA INC (NOVT)

Glastra Matthijs โ€” Director
Feb 2, 2026
Sale
Shares
3,606
Price
$134.52
Total Value
$485.08K
Shares Held After
67,761
% of Holdings
5.1%

Dave Inc./DE (DAVE)

POPE MICHAEL W โ€” Director
Feb 2, 2026
Sale
Shares
544
Price
$162.00
Total Value
$88.13K
Shares Held After
5,831
% of Holdings
8.5%

INSMED Inc (INSM)

Flammer Martina M.D. โ€” Chief Medical Officer
Feb 2, 2026
Sale
Shares
100
Price
$156.86
Total Value
$15.69K
Shares Held After
84,907
% of Holdings
0.1%

INSMED Inc (INSM)

Flammer Martina M.D. โ€” Chief Medical Officer
Feb 2, 2026
Sale
Shares
3,042
Price
$155.46
Total Value
$472.91K
Shares Held After
85,007
% of Holdings
3.5%

INSMED Inc (INSM)

Flammer Martina M.D. โ€” Chief Medical Officer
Feb 2, 2026
Sale
Shares
3,349
Price
$154.56
Total Value
$517.62K
Shares Held After
88,049
% of Holdings
3.7%

INSMED Inc (INSM)

Flammer Martina M.D. โ€” Chief Medical Officer
Feb 2, 2026
Sale
Shares
928
Price
$153.16
Total Value
$142.13K
Shares Held After
91,398
% of Holdings
1.0%

INSMED Inc (INSM)

Flammer Martina M.D. โ€” Chief Medical Officer
Feb 2, 2026
Sale
Shares
563
Price
$152.06
Total Value
$85.61K
Shares Held After
92,326
% of Holdings
0.6%

Burlington Stores, Inc. (BURL)

Vecchio Jennifer โ€” Group President and CMO
Feb 2, 2026
Sale
Shares
57
Price
$299.96
Total Value
$17.10K
Shares Held After
62,494
% of Holdings
0.1%

Burlington Stores, Inc. (BURL)

Vecchio Jennifer โ€” Group President and CMO
Feb 2, 2026
Sale
Shares
177
Price
$298.83
Total Value
$52.89K
Shares Held After
62,551
% of Holdings
0.3%

Burlington Stores, Inc. (BURL)

Vecchio Jennifer โ€” Group President and CMO
Feb 2, 2026
Sale
Shares
37
Price
$296.83
Total Value
$10.98K
Shares Held After
62,728
% of Holdings
0.1%

Burlington Stores, Inc. (BURL)

Vecchio Jennifer โ€” Group President and CMO
Feb 2, 2026
Sale
Shares
109
Price
$295.86
Total Value
$32.25K
Shares Held After
62,765
% of Holdings
0.2%

Burlington Stores, Inc. (BURL)

Vecchio Jennifer โ€” Group President and CMO
Feb 2, 2026
Sale
Shares
39
Price
$294.12
Total Value
$11.47K
Shares Held After
62,874
% of Holdings
0.1%

Akebia Therapeutics, Inc. (AKBA)

Malabre Richard C โ€” SVP, Chief Accounting Officer
Feb 2, 2026
Sale
Shares
13,382
Price
$1.39
Total Value
$18.60K
Shares Held After
299,390
% of Holdings
4.3%

Akebia Therapeutics, Inc. (AKBA)

Malabre Richard C โ€” SVP, Chief Accounting Officer
Feb 2, 2026
Sale
Shares
36,142
Price
$1.39
Total Value
$50.24K
Shares Held After
312,772
% of Holdings
10.4%
Version: v26.3.33